| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.13 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |